Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009

Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010

Published:2012-09 Issue:1 Volume:74 Page:62-67
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Hoban Daryl J.,Lascols Christine,Nicolle Lindsay E.,Badal Robert,Bouchillon Sam,Hackel Meredith,Hawser Stephen

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics;Alhambra;J Antimicrob Chemother,2004

2. Management of complicated urinary tract infections in the era of antimicrobial resistance;Bader;Postgrad Med,2010

3. Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant Gram-negative bacteria;Bogaerts;Antimicrob Agents Chemother,2011

4. Performance standards for antimicrobial susceptibility testing: 21st informational supplement (M100–S22);Clinical and Laboratory Standards Institute (CLSI),2012

5. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe, Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000);Gordon;Diagn Microbiol Infect Dis,2003

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of early use of Carbapenems perioperatively for urolithiasis with ESBL-producing Escherichia coli;BMC Urology;2024-09-06

2. Are Empirical Treatments Compatible with the Pattern of Antibiotic Sensitivity in Urinary Tract Infections?;SN Comprehensive Clinical Medicine;2023-06-02

3. Extended-Spectrum β-Lactamase and Carbapenemase-Producing Gram-Negative Bacteria and Associated Factors Among Patients Suspected of Community and Hospital-Acquired Urinary Tract Infections at Ayder Comprehensive Specialized Hospital, Tigrai, Ethiopia;Infection and Drug Resistance;2023-06

4. In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020;International Journal of Antimicrobial Agents;2023-06

5. Differences in Virulence Factors and Antimicrobial Susceptibility of Uropathogenic Enterococcus spp. Strains in a Rural Area of Uganda and a Spanish Secondary Hospital;Tropical Medicine and Infectious Disease;2023-05-16